News

Celebrating Excellence: NUHS Tribute Awards Shine Bright

Celebrating Excellence: NUHS Tribute Awards Shine Bright

NUHS Tribute Awards Ceremony Celebrates Remarkable Healthcare Professionals

The National University Health System (NUHS) recently celebrated the accomplishments of 77 exceptional individuals and four dedicated teams that are driving transformative changes in healthcare. With a focus on extending care beyond hospital walls, NUHS is redefining models of healthcare delivery to foster community well-being.

Introduction of the Emeritus Fellow Title

This year marks a pivotal moment for NUHS as it introduces the distinguished Emeritus Fellow title, highlighting the contributions of outstanding healthcare professionals. The Master Clinician award category has also been expanded to recognize excellence across various disciplines, including nurses and allied health professionals.

Honoring Long-Lasting Contributions

The inaugural Emeritus Fellow title is awarded to four distinguished individuals, all pioneers in nursing, diagnostics, and pharmacy:

  • Dr. Emily Ang, a Senior Nurse Advisor at Alexandra Hospital, has been a leading figure in nursing leadership for nearly two decades.
  • Mrs. Lee Siu Yin, a Senior Nurse Mentor, has greatly influenced advanced practice nursing and continues to mentor upcoming nurses.
  • Dr. Tyrone Goh, an Advisor at NUHS and CEO of NUH Referral Laboratory, has advanced diagnostics and clinical support services.
  • Mr. Wu Tuck Seng, a pioneer in pharmacy innovation, developed the first inpatient pharmacy automation system in Asia-Pacific.

This year, an additional 62 recipients will be honored with the NUHS Pinnacle Awards, across several categories aimed at recognizing outstanding achievements in diverse fields.

A Commitment to Excellence

Professor Yeoh Khay Guan, the Chief Executive of NUHS, emphasized that the remarkable contributions of their healthcare professionals enable world-class patient care, which is vital for transforming healthcare systems. The dedication of the 17,000-strong healthcare family at NUHS serves as the driving force in this mission.

Expanding Care Beyond Hospitals

Since its establishment in 2020, the NUHS@Home program has significantly expanded, allowing patients to receive hospital-level care within their homes. To date, it has managed over 2,900 patients, effectively saving more than 17,000 bed days.

In 2024, NUHS@Home extended its services to acutely ill patients in nursing homes, leading to further awards and recognition for its innovative model of care.

Innovative Patient Care Solutions

The NCIS On-The-Go program, which launched in 2017, has also experienced immense growth. This community-based cancer treatment program has expanded its services and established new clinics, making access to care easier and faster for patients in need.

As digital transformation becomes a priority, the NUHS is working on accelerating the adoption of AI and various technologies to streamline processes and promote sustainability in patient care.

Advancing Digital Health Initiatives

Dr. Alexander Yip is leading the initiative to create Singapore's first fully integrated virtual hospital, the Alexandra Virtual Hospital (AVH). This pioneering model seeks to enhance patient care through innovative health devices and video technology, creating seamless care experiences.

Looking forward, Dr. Yip's team is set to expand AVH's capabilities, focusing on remote patient monitoring to address the challenges posed by manpower shortages and increasing patient demands.

Celebrating Innovation and Leadership in Healthcare

The achievements recognized through the NUHS Tribute Awards not only highlight exceptional individual contributions but also underscore the collaborative spirit inherent in advancing healthcare. NUHS remains steadfast in its mission to cultivate a patient-centered and sustainable health system.

About the National University Health System (NUHS)

NUHS is devoted to innovatively transforming healthcare through research, clinical trials, and the development of better technologies. By partnering with like-minded institutions, NUHS is dedicated to enhancing healthcare delivery, education, and patient outcomes.

With a broad network of hospitals and specialties under its governance, NUHS integrates patient care with health sciences education and research, fostering a collaborative approach to improve community health.

Frequently Asked Questions

1. What is the purpose of the NUHS Tribute Awards?

The NUHS Tribute Awards honor healthcare professionals for their outstanding contributions to patient care, research, and education.

2. Who was awarded the Emeritus Fellow title this year?

This year, four remarkable professionals were awarded the Emeritus Fellow title for their pioneering contributions in healthcare.

3. How has the NUHS@Home program impacted patient care?

The NUHS@Home program allows patients to receive hospital-level care at home, significantly saving bed days and enhancing their recovery experience.

4. What innovative technologies is NUHS implementing?

NUHS is leading the development of Singapore's first integrated virtual hospital, utilizing AI and connected health devices for improved patient care.

5. How does NUHS support its healthcare professionals?

NUHS supports its healthcare professionals through awards and recognition, fostering a culture of excellence and commitment to patient care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Piramal Pharma FY27 Q2 Results: Robust Growth & Optimism

Updated Category News Views 38

A Solid Performance from Piramal Pharma The numbers are in, and it's looking pretty good for Piramal Pharma Limited this time around. Their second quarter of fiscal year 2027 has seen some fireworks, and I'm not talking about some half-baked confetti deal. We're talking genuine growth and solid metrics here. Revenue and Profit Surge The headline? Revenue jumped a whopping...

Continue Reading
NACCO Industries Preps for Q3 Results and Call

Updated Category News Views 48

Anticipation Builds for NACCO's Q3 Financial Insights From the streets of Cleveland, NACCO Industries is ramping up to release their third quarter financial results for 2026. Mark your calendars for November 4, just after the market packs up for the day. Now, isn't it something to watch how these earnings reports seem to become a spectacle all their own? Promising...

Continue Reading
Sands China Unveils $1B Senior Notes, Eyes Debt Maneuvering

Updated Category News Views 43

A New Play in the Sands Well, here we go again with Las Vegas Sands (NYSE: LVS) putting together another financial puzzle. Sands China, their big performer over in Macao, is selling off $1 billion in senior unsecured notes. They're splitting it with $700 million at 6.400% due in 2032 and $300 million at a heftier 6.700% maturing in 2033. This feels like classic strategic...

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 87

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
Corgi Insurance Eyes $100B Auto Market with New Launch

Updated Category News Views 47

Leaping Into a Booming Market Well, it looks like someone lit a fire under Corgi Insurance, and they're ready to chase bigger bones. They’ve just rolled out a product called Corgi Business Auto, signaling quite a bold move into the hefty, nearly $100 billion U.S. commercial auto insurance arena. Now, as an old hand at this game, my ears perk up whenever I see a player...

Continue Reading
SK hynix Hits $104 Trillion in Revenue, Boosts Dividends

Updated Category News Views 27

Phenomenal Financial Benchmark You gotta give it to SK hynix. They've just blown past that 100 trillion won ceiling like it's a minor bump on the highway. For folks tracking big numbers in memory semiconductors, this is fireworks-worthy. We're talking 104.6155 trillion won in revenue, a solid 83.3338 trillion won in operating profit, and a 39.7756 trillion won net profit....

Continue Reading
Aker Solutions' Q3 2026: Steady Growth Amid Milestones

Updated Category News Views 30

Aker Solutions Hits Its Stride in Q3 2026 Alright, let's talk Aker Solutions ASA and their third-quarter results for 2026. This isn't their first rodeo with solid financial performance, and it sure looks like they're keeping the ball rolling this time as well. Word on the street in the Oil & Energy sector is that Aker has managed to stick to their plan and tick off...

Continue Reading
Red Robin Faces Board Shakeup and Financial Strategy Shift

Updated Category News Views 28

Turbulence on the Board But Strategic Moves on Track Well, it's not every day you hear about a double departure from Red Robin's board, right on the heels of some big financial reshuffling. Two directors, James C. Pappas and Christopher Martin, decided to abandon ship effective October 23, 2026. Given their ties to JCP Investment and Jumana Capital, this isn't just a...

Continue Reading
Yellow River Basin Firms Focus on Global Expansion

Updated Category News Views 0

Shandong's Bold Move on the Global Stage Imagine the bustling city of Jinan, Shandong's capital, humming with the energy of ambitious enterprises ready to leap into the global arena. That's exactly what unfolded at the conference aimed at forging international ties under the Belt and Road Initiative (BRI). For those out of the loop, this ain't just another business...

Continue Reading
Kyungtz'e Eosan Sooryukje: Honoring Spirits and History

Updated Category News Views 48

An Enchanting Ritual Comes to NYC Some things transcend the humdrum of everyday life, and right now, New York's set to witness exactly that. It's not every day you get treated to Korea's deep-rooted Buddhist traditions, but come November 13 and 14, that's precisely what's in store. The Korean Cultural Center New York (KCCNY) is bringing Kyungtz'e Eosan Sooryukje to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Recent Class Action Against Perrigo Company

Updated Category News Views 226

Recent Developments on the Perrigo Company Lawsuit As investors look to safeguard their interests, recent legal actions have drawn significant attention, particularly regarding Perrigo Company plc (NYSE: PRGO). In this developing case, a shareholder filed a securities class action lawsuit, reflecting the concerns of many who have invested in the company. Who is Affected...

Continue Reading
Nurix Therapeutics Welcomes Anil Kapur to Its Board

Updated Category News Views 226

Nurix Therapeutics Welcomes Anil Kapur to Its Board SAN FRANCISCO - Nurix Therapeutics, Inc. (NASDAQ:NRIX) has made a significant move in strengthening its board of directors by appointing Anil Kapur, a seasoned professional with extensive experience in the pharmaceutical sector. His addition is anticipated to provide valuable insights as Nurix gears up to transition its...

Continue Reading
Investors of Rocket Pharmaceuticals Face Deadline Over Losses

Updated Category News Views 134

Urgent Deadline for Rocket Pharmaceuticals Investors Investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) should be acutely aware of an important deadline looming for filing a lead plaintiff motion related to significant recent developments concerning the company's stock and performance. Those who acquired securities between specified dates are specifically targeted...

Continue Reading
GriefShare Unveils Digital Resources for Global Support Expansion

Updated Category News Views 242

GriefShare’s Expansion into Digital Support Tools In an exciting development, GriefShare, a leader in church-based grief support, is breaking down geographical barriers with the introduction of digital workbooks designed for international churches. This initiative allows Christians around the world to access valuable grief support resources without the hassle of...

Continue Reading
Brian Armstrong's Optimism: Key Crypto Legislation Could Pass Soon

Updated Category News Views 246

Coinbase CEO's Vision for Future Regulations Brian Armstrong, the CEO of Coinbase Global Inc. (NASDAQ: COIN), recently shared his positive outlook regarding the future of cryptocurrency legislation in the U.S. He believes that significant progress is being made across the aisle, as both Democrats and Republicans appear to agree on the need for clarity in regulation....

Continue Reading